首页> 外文期刊>Veterinary Microbiology >Cross-protection study of a Mannheimia haemolytica serotype 1 vaccine against acute pasteurellosis in lambs induced by a serotype 2 strain
【24h】

Cross-protection study of a Mannheimia haemolytica serotype 1 vaccine against acute pasteurellosis in lambs induced by a serotype 2 strain

机译:溶血性曼海姆氏菌1型血清型疫苗针对2型血清型引起的羔羊急性巴氏杆菌病的交叉保护研究

获取原文
获取原文并翻译 | 示例
       

摘要

Ovine pneumonia is an economic important disease worldwide for the sheep industry. Multiple serotypes (S) of Mannheimia haemolytica are involved in the disease and S2 and S1 are the most frequent isolates associated with lung lesions in sheep. Vaccines based on some M. haemolytica S2 strains have been shown to have poor immunogenicity. The objective of this study was to determine the cross-protection effect of an S1 strain based vaccine, Bovilis MH, in sheep against an experimental challenge with an S2 strain. Lambs (n = 12) in the vaccine group were injected subcutaneously with 1 ml of the Bovilis MH vaccine, and revaccinated 4 weeks later, while the control group (n = 12) received 1 ml of saline at each occasion. Two weeks after revaccination, all lambs were challenged intratracheally with parainfluenza virus 3, and with an M. haemolytica S2 strain at day 7 post-viral challenge. The proportion of animals having pyrexia in the first 2 days post-bacterial challenge was significantly less in the vaccine group compared to the control group (P 0.05). The animals in the vaccine group had significantly lower dyspnoea scores and lung/bodyweight ratio than those in the control group (P 0.05). The vaccine provided 49.1% overall protection. Prior to the challenge, the vaccinated animals had significantly higher titres of antibodies to S1 and S2 whole cell antigens and to leukotoxins produced by S1 and S2 strains compared to the control animals (P 0.05). The S1 strain vaccine provided considerable cross-protection against the S2 strain challenge. (C) 2015 Elsevier B.V. All rights reserved.
机译:绵羊肺炎是全球绵羊产业的重要经济疾病。溶血曼海姆氏菌的多种血清型(S)参与该疾病,而S2和S1是与绵羊肺部损伤相关的最常见分离株。已显示基于某些溶血支原体S2株的疫苗免疫原性较差。这项研究的目的是确定基于S1菌株的疫苗Bovilis MH在绵羊中针对S2菌株的实验性攻击的交叉保护作用。疫苗组中的小羊(n = 12)被皮下注射1 ml Bovilis MH疫苗,并在4周后重新接种,而对照组(n = 12)则每次都接受1 ml盐水。再次接种后两周,在病毒激发后第7天,所有小羊都在气管内用副流感病毒3和溶血支原体S2菌株进行攻击。与对照组相比,疫苗接种后头两天有发热的动物比例明显减少(P <0.05)。疫苗组的动物呼吸困难评分和肺/体重比明显低于对照组(P <0.05)。该疫苗提供了49.1%的总体保护率。在攻击之前,与对照动物相比,接种疫苗的动物对S1和S2全细胞抗原以及S1和S2菌株产生的白细胞毒素的抗体效价明显更高(P <0.05)。 S1株疫苗提供了针对S2株挑战的相当大的交叉保护。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号